Status Approved
First Submitted Date
2020/05/21
Registered Date
2020/07/30
Last Updated Date
2020/10/07
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0005270 |
---|---|
Unique Protocol ID | 2020-0782 |
Public/Brief Title | Effect of digital hearing aids with sound therapy (sound generator) |
Scientific Title | Effect of digital hearing aids with sound therapy (sound generator) for tinnitus with hearing loss |
Acronym | HATINN |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status | Submitted pending |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | 2020-0782 |
Approval Date | 2020-05-18 |
Institutional Review Board Name | Asan Medical Center Institutional Review Board |
Institutional Review Board Address | 88, Olympic-ro 43-gil, Songpa-gu, Seoul |
Institutional Review Board Telephone | 02-3010-7166 |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Jong Woo Jung |
Title | Professor |
Telephone | +82-2-3010-3718 |
Affiliation | Asan Medical Center |
Address | 86 Olympic-ro 43-gil, Songpa-gu, Seoul, Korea 05505 |
Contact Person for Public Queries | |
Name | Yehree Kim |
Title | Clinical Fellow |
Telephone | +82-2-3010-0036 |
Affiliation | Asan Medical Center |
Address | 86 Olympic-ro 43-gil, Songpa-gu, Seoul, Korea 05505 |
Contact Person for Updating Information | |
Name | Yehree Kim |
Title | Clinical Fellow |
Telephone | +82-2-3010-0036 |
Affiliation | Asan Medical Center |
Address | 86 Olympic-ro 43-gil, Songpa-gu, Seoul, Korea 05505 |
4. Status
Study Site | Single | |
---|---|---|
Overall Recruitment Status | Not yet recruiting | |
Date of First Enrollment | 2020-08-03 Anticipated | |
Target Number of Participant | 40 | |
Primary Completion Date | 2022-12-31 , Anticipated | |
Study Completion Date | 2022-12-31 , Anticipated | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | Asan Medical Center | |
Recruitment Status | Not yet recruiting | |
Date of First Enrollment | 2020-08-03 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | Asan Medical Center |
Organization Type | Medical Institute |
Project ID |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | Asan Medical Center |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | This study primarily aims to validate the effect of sound generators on alleviation of tinnitus. Our secondary aim is to check the effect of sound generation on hearing aid performance. In the control group, we will prescribe RIC type hearing aid and the patients will use the hearing aid for 7 months. In the experimental group, we will prescribe RIC type hearing aid with Zen program and the patients will use the program for 7 months. Tinnitogram, tinnitus handicap inventory, pure tone audiometry, speech detection test, impedance audiometry, hearing in noise test will be performed at 1,4,7 months after hearing aid use. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Treatment |
Phase | Not applicable |
Intervention Model | Parallel |
Blinding/Masking | Open |
Allocation | RCT |
Intervention Type | Medical Device |
Intervention Description | 1. Experimental group : Prescribe RIC type hearing aid with Zen program 2. Control : Prescribe RIC type hearing aid |
Number of Arms | 2 |
Arm 1 |
Arm Label Sound generator |
Target Number of Participant 20 |
|
Arm Type Experimental |
|
Arm Description Prescribe RIC type hearing aid with Zen program and use the program for 7 months. |
|
Arm 2 |
Arm Label Hearing aid |
Target Number of Participant 20 |
|
Arm Type Active comparator |
|
Arm Description Prescribe RIC type hearing aid and use the hearing aid for 7 months. |
9. Subject Eligibility
Condition(s)/Problem(s) |
* (H60-H95)Diseases of the ear and mastoid process (H90.5)Sensorineural hearing loss, unspecified Sensorineural hearing loss, tinnitus |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 19Year~64Year |
|
Description 1. Patients over the age of 19 and below 65 2. Patients with unilateral tinnitus and unilateral/bilateral sensorineural hearing loss that has lasted longer than 3 months 3. Patients with continuous tinnitus 4. Sensorineural hearing loss patients with a speech discrimination score better than 50% |
|
Exclusion Criteria |
1. Patients with a history of middle ear diseases or surgery that may prohibit the use of hearing aids 2. Patients with hyperacusis 3. Patients with pulsatile tinnitus 4. Patients with Meniere's disease, CPA tumor, superior canal dehiscence syndrome, otitis media 5. Patients with cognitive impiarment (dementia, Alzheimer's diseas) |
Healthy Volunteers | No |
10. Outcome Measure(s)
Type of Primary Outcome | Efficacy | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | Tinnitogram, tinnitus handicap inventory |
|
Timepoint | 1,4,7 months after hearing aid use |
|
Secondary Outcome(s) 1 | ||
Outcome | Pure tone audiometry, speech detection test, impedance audiometry, hearing in noise test |
|
Timepoint | 1,4,7 months after hearing aid use |
11. Study Results and Publication
Result Registered | No |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | No |
---|
TOP
BOTTOM
화면 최하단으로 이동